These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22875759)

  • 1. Clinically relevant measures of fit? A note of caution.
    Cook NR
    Am J Epidemiol; 2012 Sep; 176(6):488-91. PubMed ID: 22875759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context.
    Kerr KF; Bansal A; Pepe MS
    Am J Epidemiol; 2012 Sep; 176(6):482-7. PubMed ID: 22875756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting incremental value of markers added to risk prediction models.
    Pencina MJ; D'Agostino RB; Pencina KM; Janssens AC; Greenland P
    Am J Epidemiol; 2012 Sep; 176(6):473-81. PubMed ID: 22875755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pencina et al. respond to "The incremental value of new markers" and "Clinically relevant measures? A note of caution".
    Pencina MJ; D'Agostino RB; Demler OV; Janssens AC; Greenland P
    Am J Epidemiol; 2012 Sep; 176(6):492-4. PubMed ID: 22875757
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.
    Pencina MJ; D'Agostino RB; Demler OV
    Stat Med; 2012 Jan; 31(2):101-13. PubMed ID: 22147389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.
    Cook NR; Ridker PM
    Ann Intern Med; 2009 Jun; 150(11):795-802. PubMed ID: 19487714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve.
    Mihaescu R; van Zitteren M; van Hoek M; Sijbrands EJ; Uitterlinden AG; Witteman JC; Hofman A; Hunink MG; van Duijn CM; Janssens AC
    Am J Epidemiol; 2010 Aug; 172(3):353-61. PubMed ID: 20562194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves.
    Grund B; Sabin C
    Curr Opin HIV AIDS; 2010 Nov; 5(6):473-9. PubMed ID: 20978390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.
    Li J; Jiang B; Fine JP
    Biostatistics; 2013 Apr; 14(2):382-94. PubMed ID: 23197381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power-integrated discriminant improvement: An accurate measure of the incremental predictive value of additional biomarkers.
    Hayashi K; Eguchi S
    Stat Med; 2019 Jun; 38(14):2589-2604. PubMed ID: 30859601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.
    Enserro DM; Demler OV; Pencina MJ; D'Agostino RB
    Stat Med; 2019 Sep; 38(20):3817-3831. PubMed ID: 31211443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simpson's paradox in the integrated discrimination improvement.
    Chipman J; Braun D
    Stat Med; 2017 Dec; 36(28):4468-4481. PubMed ID: 29160558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population.
    McGeechan K; Macaskill P; Irwig L; Bossuyt PM
    BMC Med Res Methodol; 2014 Jul; 14():86. PubMed ID: 24989719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the performance of prediction models: a framework for traditional and novel measures.
    Steyerberg EW; Vickers AJ; Cook NR; Gerds T; Gonen M; Obuchowski N; Pencina MJ; Kattan MW
    Epidemiology; 2010 Jan; 21(1):128-38. PubMed ID: 20010215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First things first: risk model performance metrics should reflect the clinical application.
    Kerr KF; Janes H
    Stat Med; 2017 Dec; 36(28):4503-4508. PubMed ID: 29156498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of reclassification statistics in comparing risk prediction models.
    Cook NR; Paynter NP
    Biom J; 2011 Mar; 53(2):237-58. PubMed ID: 21294152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inference for reclassification statistics under nested and non-nested models for biomarker evaluation.
    Shao F; Li J; Fine J; Wong WK; Pencina M
    Biomarkers; 2015; 20(4):240-52. PubMed ID: 26301882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk reclassification at 10 years.
    Cook NR; Demler OV; Paynter NP
    Stat Med; 2017 Dec; 36(28):4498-4502. PubMed ID: 29156504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.